Gene therapy for malignant neoplasms of the CNS

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 3, 1996, Pages

  Culver, K W ^a  

^a OncorPharm   (United States)

Author keywords

Brain tumor; Ganciclovir; Herpes Simplex thymidine; Kinase; Retroviral vectors

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; GANCICLOVIR; INTERLEUKIN 2; SOMATOMEDIN C; THYMIDINE KINASE;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; BONE MARROW TOXICITY; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL TRIAL; CONFERENCE PAPER; GENE INSERTION; GENE THERAPY; GENE TRANSFER; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS GENE;

ANIMALS; ANTIVIRAL AGENTS; BRAIN NEOPLASMS; CHILD; CLINICAL TRIALS; DNA, ANTISENSE; DRUG RESISTANCE, NEOPLASM; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-2; MICE; NEOPLASM RECURRENCE, LOCAL; P-GLYCOPROTEIN; RECOMBINANT PROTEINS; SALVAGE THERAPY; STEM CELLS; THYMIDINE KINASE; TRANSFECTION;

EID: 0030476553     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Blaese RM, Culver KW, Anderson WF. The ADA human gene therapy clinical protocol. Hum Gene Ther 1990; 1: 331-362.
2. Culver KW. Gene Therapy: A Primer for Physicians. Mary Ann Liebert: New York, 1996.
3. Oldfield EH, Ram Z, Culver KW, Blaese RM. A clinical protocol: gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993; 4: 36-69.
4. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-5281.
5. Ram Z, Culver KW, Walbridge S et al. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993; 53: 83-88.
6. Culver KW, Ram Z, Walbridge S et al. In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
7. Freeman SM, Abboud CN, Whartenby KA et al. The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-5283.
8. Bi WL, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV-tk retroviral gene therapy. Hum Gen Ther 1993; 4: 725-732.
9. Ram Z, Culver KW, Walbridge S et al. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J Neurosurg 1993; 79: 400-407.
10. Ram Z. Gene therapy for solid brain tumors and leptomeningeal cancer. Cancer Gene Ther 1994; 1: 146.
11. Culver KW, Van Gilder J, Link CJ Jr et al. Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther 1993; 5: 343-377.
12. Raffel C, Culver KW, Kohn D et al. Gene therapy for the treatment of recurrent pediatric malignant astrocytomas using in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther 1994; 5: 863-890.
13. Culver KW, Blaese RM. Gene therapy for cancer. Trends Genet 1994; 10: 174-178.
14. Le Gal La Salle G, Robert JJ, Berrard S et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993; 259: 988-990.
15. Chen S-H, Shine HD, Goodman JC et al. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994; 91: 3054-3057.
16. Trojan J, Blossey BK, Johnson TR et al. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of the insulin-like growth factor-1. Proc Natl Acad Sci USA 1992; 89: 4874-4878.
17. Trojan J, Johnson TR, Rudin SD et al. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor 1 RNA. Science 1993; 259: 94-97.
18. Fearon ER, Pardoll DM, Itaya T et al. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 1990; 60: 397-403.
19. Galski H, Sullivan M, Wilingham MC et al. Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: Resistance to daunomycin-induced leukopenia. Mol Cell Biol 1989; 9: 4357-1363.
20. Sorrentino BP, Brandt SJ, Bodine D et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 1992; 257: 99-103.